ResMed | RMD - Ebitda

Stock Price
251.41
Daily Change
-3.33 -1.31%
Monthly
2.47%
Yearly
4.55%
Q1 Forecast
250.35

ResMed reported $547.48M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Ansell USD 192.8M 28.7M Jun/2025
AtriCure USD 17.8M 2.45M Sep/2025
Baxter International USD 462M 137M Jun/2025
Cochlear AUD 292.9M 30.1M Jun/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
CSL USD 1.96B 1.27B Jun/2025
Dexcom USD 368.4M 59.6M Sep/2025
Edwards Lifesciences USD 469M 57.7M Jun/2025
Fisher Paykel Healthcare NZD 364M 78.5M Jun/2025
Globus Medical USD 252.6M 43.92M Sep/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Idexx Laboratories USD 391.47M 17.97M Sep/2025
Insulet USD 160M 2.5M Sep/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
Masimo USD 72M 42.6M Jun/2025
Medtronic USD 2.44B 139M Sep/2025
Philips EUR 738M 9M Sep/2025
Ramsay Health Care AUD 1.11B 84.1M Jun/2025
ResMed USD 547.48M 27.46M Dec/2025
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Steris USD 367.2M 13.42M Jun/2025
Teleflex USD 207.62M 15.28M Jun/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025